Altered expression of transforming growth factor-beta in Alzheimer's disease

Neurology
K C FlandersM B Sporn

Abstract

We compared immunohistochemical expression of the transforming growth factor-betas (TGF-beta 1, TGF-beta 2, and TGF-beta 3) using brain tissue from patients with nondominantly inherited Alzheimer's disease (NDAD) (n = 9), autosomal dominantly inherited Alzheimer's disease with linkage to 14q24.3 (FAD-14) (n = 4), and cognitively normal controls (n = 10) to determine whether their pathologic changes are associated with an altered distribution of the TGF-betas. We found increased expression of TGF-beta 2 in large, tangle-bearing neurons with widespread staining of glia in NDAD and FAD-14 patients compared with control cases. This result was confirmed with sandwich ELISA assays of brain tissue, which showed TGF-beta 2 levels in AD and NDAD to average 3.2 times the average level of control cases. Despite proximity of TGF-beta 1 and TGF-beta 3 to the sites of susceptibility loci on chromosomes 19 and 14, we did not find that TGF-beta 1 and TGF-beta 3 were selectively altered in any AD subtypes. However, selective induction of TGF-beta 2 may occur in NDAD and FAD-14.

Citations

Jun 8, 2001·Journal of Neuroscience Research·L Yuan, A H Neufeld
Oct 7, 2006·Molecular Diagnosis & Therapy·Christi Kolarcik, Robert Bowser
Aug 19, 2011·Cell and Tissue Research·Kristina Beck, Christian Schachtrup
Jul 12, 2012·Journal of Neural Transmission·Wei-wei ChangYing-shui Yao
May 14, 1998·Neuroscience and Biobehavioral Reviews·P Malek-Ahmadi
Dec 14, 2002·Brain Research. Molecular Brain Research·Hyoung-Chun KimJau-Shyong Hong
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray
Feb 14, 1998·Progress in Neurobiology·K C FlandersC F Lippa
Jun 10, 1998·Cytokine & Growth Factor Reviews·B M Pratt, J M McPherson
Oct 10, 2002·Acta Neurologica Scandinavica·K HouiK Inoue
Oct 17, 1998·Neuropathology and Applied Neurobiology·H TashiroT Iwaki
Oct 29, 1998·Mediators of Inflammation·V A VincentA M Van Dam
Oct 1, 1996·The Journal of Experimental Medicine·Y VodovotzM B Sporn
Oct 18, 2005·Molecular and Cellular Biology·Yuichi HashimotoMasaaki Matsuoka
Mar 29, 2012·Current Gerontology and Geriatrics Research·Donna M Wilcock
Feb 12, 1998·The Journal of Clinical Investigation·E M Sternberg
Nov 3, 2006·The Journal of Clinical Investigation·Ina TesseurTony Wyss-Coray
Dec 27, 2013·International Journal of Alzheimer's Disease·Xin Yi ChooAlexandra Grubman
Jul 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sitt Wai FongGuy S Bewick
Apr 9, 2010·The International Journal of Neuroscience·Atsushi NoguchiMasaaki Matsuoka
Feb 7, 2007·Journal of Neuropathology and Experimental Neurology·Katy A Chalmers, Seth Love
May 13, 2006·Journal of Neuropathology and Experimental Neurology·Frank-Peter WachsLudwig Aigner
Jul 12, 2011·Trends in Neurosciences·Kerstin KrieglsteinChristian Alzheimer
May 10, 2002·The American Journal of Pathology·Paula Grammas, Roma Ovase
Jun 27, 2009·Neuroscience·S BaigS Love
Sep 10, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Sylvain LesnéDenis Vivien
Oct 9, 2007·Brain Research Reviews·Lin Li, Christian Hölscher
Jun 24, 2004·Journal of Neuroscience Research·Marni E Harris-WhiteSally A Frautschy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.